Asunto(s)
Anisakis/inmunología , Hipersensibilidad/epidemiología , Adolescente , Alérgenos/inmunología , Animales , Niño , Preescolar , Femenino , Hipersensibilidad a los Alimentos/etiología , Hipersensibilidad a los Alimentos/inmunología , Humanos , Lactante , Masculino , Prevalencia , Alimentos Marinos/efectos adversos , Pruebas Cutáneas , Encuestas y CuestionariosRESUMEN
BACKGROUND: Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) or eosinophil-derived neurotoxin (EDN) are released by eosinophil granulocytes in allergic diseases. Serum ECP (s-ECP) levels have been correlated with disease activity in atopic dermatitis (AD) in adults and young patients, and high urinary EPX (u-EPX) levels in asthmatic patients seem to reflect active disease. A relationship between AD severity and u-EPX concentration in young children has not been previously studied. OBJECTIVE: This study was performed to evaluate whether the severity of AD in infants and young children was correlated with s-ECP and u-EPX levels. METHODS: Fifty-four infants and children (mean age, 17.7 months; range, 4-48 months) with AD and without other allergic conditions were evaluated. The severity of AD was measured by using the SCORAD index. S-ECP, serum total IgE, serum-specific IgE for common allergens, and peripheral blood eosinophil counts (PBECs) were determined. In forty-two children u-EPX was also measured. Seven age-matched control patients underwent the same determinations. RESULTS: S-ECP and u-EPX were significantly higher in children with AD than in control children (mean, 23.9 vs 3.5 microg/dL [P <.001] and 57.7 vs 6.0 microg/mmol creatinine [P <.001]). A significant correlation was found between SCORAD and s-ECP (P =.002), u-EPX (P =.01), and PBECs (P =.01) and between symptom index and uEPX (P =.0004). PBECs were strongly correlated to s-ECP and u-EPX (P <.0001). However, 5 patients with moderate and severe AD (11.9%) showed low levels of s-ECP, u-EPX, and PBECs. CONCLUSION: S-ECP and u-EPX were useful markers of AD activity in infants and young children. When taken together, the two determinations could give more information about the clinical course of the illness. Some patients seemed to have clinical exacerbations without an involvement of eosinophils and their products.
Asunto(s)
Proteínas Sanguíneas/metabolismo , Proteínas Sanguíneas/orina , Dermatitis Atópica/sangre , Dermatitis Atópica/orina , Eosinófilos/metabolismo , Ribonucleasas , Preescolar , Dermatitis Atópica/inmunología , Dermatitis Atópica/patología , Proteínas en los Gránulos del Eosinófilo , Neurotoxina Derivada del Eosinófilo , Femenino , Humanos , Inmunoglobulina E/sangre , Lactante , Recuento de Leucocitos , Masculino , Índice de Severidad de la EnfermedadAsunto(s)
Árabes/estadística & datos numéricos , Enfermedad Celíaca/etnología , Refugiados , Adolescente , Adulto , Argelia/epidemiología , Enfermedad Celíaca/sangre , Enfermedad Celíaca/inmunología , Niño , Preescolar , Enfermedad Crónica , Diarrea/etiología , Insuficiencia de Crecimiento/etiología , Femenino , Humanos , Lactante , Masculino , Tamizaje Masivo , PrevalenciaRESUMEN
We investigated a peripheral serotonergic marker, i.e. platelet tritiated imipramine (3H-IMI) binding sites, which are part of the 5-HT transporter complex similar to that present in the brain, in 20 patients affected by coeliac disease (CD), as compared with 20 healthy controls. Platelet membranes and 3H-IMI binding were carried out according to a standardized protocol. The results showed that coeliac patients had significantly lower 3H-IMI binding sites than controls. This finding would suggest the presence of a dysfunction at the level of the 5-HT transporter that might underline the psychic disturbances frequently observed in coeliac patients.
Asunto(s)
Plaquetas/metabolismo , Proteínas Portadoras/metabolismo , Enfermedad Celíaca/sangre , Glicoproteínas/metabolismo , Serotonina/metabolismo , Adolescente , Adulto , Análisis de Varianza , Sitios de Unión , Biomarcadores/análisis , Enfermedad Celíaca/fisiopatología , Niño , Preescolar , Femenino , Humanos , Imipramina/sangre , Imipramina/metabolismo , Masculino , Serotonina/sangre , Proteínas de Transporte de Serotonina en la Membrana Plasmática , Factores Sexuales , EsplenectomíaRESUMEN
Failure to thrive is common in children with celiac disease. As alterations in the growth hormone-insulin-like growth factor I (GH-IGF-I) growth axis have been reported in these patients, we studied the behavior of growth hormone-binding proteins (GH-BPs I and II), IGF-I and its binding proteins in 14 children with celiac disease, either before or after a 6-month gluten-free diet. GH-BP II levels were significantly lower in patients during the active phase of the disease than after the diet or in comparison with control subjects, appropriate for age and sex. There was no difference in the GH-BP-I levels of patients and controls, nor did they change after the diet. Blood levels of IGF-I and IGFBP-3 were reduced before the diet in all patients while ligand blotting showed that IGFBP-2 and 1 were increased. All of these parameters normalized after the gluten-free diet. IGFBP-4 was not greatly influenced by the disease. Furthermore, we found a significant, positive correlation between GH-BP II and IGF-I or IGFBP-3 levels. The height standard deviation scores and body mass indices of the patients improved significantly after the diet. The body mass index significantly and positively correlated with GH-BP II, IGF-I or IGFBP-3 levels. In conclusion, our data show that celiac children had multiple alterations in the growth axis during the active phase of the disease which disappeared during the gluten-free diet.